Scancell Financial Year End 2025 Results
by chantal | Sep 11, 2025 | Investor Presentations, Investors, Presentations
Recent Posts
- Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- H.C. Wainwright 28th Annual Global Investment Conference
- Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced Melanoma
- Strategic transactions to unlock longer-term value
- Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
Recent Comments
No comments to show.